138 related articles for article (PubMed ID: 34391790)
1. The unique function of p130Cas in regulating the bone metabolism.
Jimi E; Honda H; Nakamura I
Pharmacol Ther; 2022 Feb; 230():107965. PubMed ID: 34391790
[TBL] [Abstract][Full Text] [Related]
2. Kif1c regulates osteoclastic bone resorption as a downstream molecule of p130Cas.
Kobayakawa M; Matsubara T; Mizokami A; Hiura F; Takakura N; Kokabu S; Matsuda M; Yasuda H; Nakamura I; Takei Y; Honda H; Hosokawa R; Jimi E
Cell Biochem Funct; 2020 Apr; 38(3):300-308. PubMed ID: 31887784
[TBL] [Abstract][Full Text] [Related]
3. p130Cas, Crk-associated substrate, plays important roles in osteoclastic bone resorption.
Nagai Y; Osawa K; Fukushima H; Tamura Y; Aoki K; Ohya K; Yasuda H; Hikiji H; Takahashi M; Seta Y; Seo S; Kurokawa M; Kato S; Honda H; Nakamura I; Maki K; Jimi E
J Bone Miner Res; 2013 Dec; 28(12):2449-62. PubMed ID: 23526406
[TBL] [Abstract][Full Text] [Related]
4. p130Cas induces bone invasion by oral squamous cell carcinoma by regulating tumor epithelial-mesenchymal transition and cell proliferation.
Yaginuma T; Gao J; Nagata K; Muroya R; Fei H; Nagano H; Chishaki S; Matsubara T; Kokabu S; Matsuo K; Kiyoshima T; Yoshioka I; Jimi E
Carcinogenesis; 2020 Aug; 41(8):1038-1048. PubMed ID: 31996896
[TBL] [Abstract][Full Text] [Related]
5. Characterization of different osteoclast phenotypes in the progression of bone invasion by oral squamous cell carcinoma.
Quan J; Hou Y; Long W; Ye S; Wang Z
Oncol Rep; 2018 Mar; 39(3):1043-1051. PubMed ID: 29286135
[TBL] [Abstract][Full Text] [Related]
6. The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts.
Vives V; Laurin M; Cres G; Larrousse P; Morichaud Z; Noel D; Côté JF; Blangy A
J Bone Miner Res; 2011 May; 26(5):1099-110. PubMed ID: 21542010
[TBL] [Abstract][Full Text] [Related]
7. Mechanical regulation of bone homeostasis through p130Cas-mediated alleviation of NF-κB activity.
Miyazaki T; Zhao Z; Ichihara Y; Yoshino D; Imamura T; Sawada K; Hayano S; Kamioka H; Mori S; Hirata H; Araki K; Kawauchi K; Shigemoto K; Tanaka S; Bonewald LF; Honda H; Shinohara M; Nagao M; Ogata T; Harada I; Sawada Y
Sci Adv; 2019 Sep; 5(9):eaau7802. PubMed ID: 31579816
[TBL] [Abstract][Full Text] [Related]
8. Disruption of NF-κB1 prevents bone loss caused by mechanical unloading.
Nakamura H; Aoki K; Masuda W; Alles N; Nagano K; Fukushima H; Osawa K; Yasuda H; Nakamura I; Mikuni-Takagaki Y; Ohya K; Maki K; Jimi E
J Bone Miner Res; 2013 Jun; 28(6):1457-67. PubMed ID: 23322687
[TBL] [Abstract][Full Text] [Related]
9. Distinct roles of p130Cas and c-Cbl in adhesion-induced or macrophage colony-stimulating factor-mediated signaling pathways in prefusion osteoclasts.
Nakamura I; Rodan GA; Duong LT
Endocrinology; 2003 Nov; 144(11):4739-41. PubMed ID: 12959979
[TBL] [Abstract][Full Text] [Related]
10. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine phosphorylation of p130Cas is involved in actin organization in osteoclasts.
Nakamura I; Jimi E; Duong LT; Sasaki T; Takahashi N; Rodan GA; Suda T
J Biol Chem; 1998 May; 273(18):11144-9. PubMed ID: 9556601
[TBL] [Abstract][Full Text] [Related]
12. Integrin αβ1, αvβ, α6β effectors p130Cas, Src and talin regulate carcinoma invasion and chemoresistance.
Sansing HA; Sarkeshik A; Yates JR; Patel V; Gutkind JS; Yamada KM; Berrier AL
Biochem Biophys Res Commun; 2011 Mar; 406(2):171-6. PubMed ID: 21291860
[TBL] [Abstract][Full Text] [Related]
13. Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption.
Hwang YS; Lee SK; Park KK; Chung WY
Oral Oncol; 2012 Jan; 48(1):40-8. PubMed ID: 21925926
[TBL] [Abstract][Full Text] [Related]
14. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
[TBL] [Abstract][Full Text] [Related]
16. Role of CrkII Signaling in RANKL-Induced Osteoclast Differentiation and Function.
Kim JH; Kim K; Kim I; Seong S; Nam KI; Lee SH; Kim KK; Kim N
J Immunol; 2016 Feb; 196(3):1123-31. PubMed ID: 26695370
[TBL] [Abstract][Full Text] [Related]
17. Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells.
Sambandam Y; Ethiraj P; Hathaway-Schrader JD; Novince CM; Panneerselvam E; Sundaram K; Reddy SV
J Cell Physiol; 2018 Aug; 233(8):6125-6134. PubMed ID: 29323724
[TBL] [Abstract][Full Text] [Related]
18. Urinary-type plasminogen activator receptor (uPAR) modulates oral cancer cell behavior with alteration in p130cas.
Shi Z; Liu Y; Johnson JJ; Stack MS
Mol Cell Biochem; 2011 Nov; 357(1-2):151-61. PubMed ID: 21630091
[TBL] [Abstract][Full Text] [Related]
19. Aesculetin Inhibits Osteoclastic Bone Resorption through Blocking Ruffled Border Formation and Lysosomal Trafficking.
Na W; Lee EJ; Kang MK; Kim YH; Kim DY; Oh H; Kim SI; Oh SY; Kang YH
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33203061
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β synthesized by stromal cells and cancer cells participates in bone resorption induced by oral squamous cell carcinoma.
Nakamura R; Kayamori K; Oue E; Sakamoto K; Harada K; Yamaguchi A
Biochem Biophys Res Commun; 2015 Mar; 458(4):777-82. PubMed ID: 25681764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
